http://orcid.org/0000-0002-9850-9520
Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Kjell Larsson, Ann Ekberg-Jansson, Caroline Stridsman, Malin Hanno & Lowie E G W Vanfleteren. (2021) Adherence to Treatment Recommendations for Chronic Obstructive Pulmonary Disease - Results from the Swedish National Airway Register. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 909-918.
Read now
Read now
Carlos Cabrera López, Enrique Mascarós, Angel Azpeitia & Elena Villarrubia. (2020) A Simplified Algorithm for the Diagnosis, Treatment, and Management of COPD in Routine Primary Care Practice. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3347-3355.
Read now
Read now
Claudio Micheletto, Fulvio Braido, Marco Contoli, Fabiano Di Marco & Pierachille Santus. (2019) A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2185-2193.
Read now
Read now
Sergey Avdeev, Zaurbek Aisanov, Vladimir Arkhipov, Andrey Belevskiy, Igor Leshchenko, Svetlana Ovcharenko, Evgeny Shmelev & Marc Miravitlles. (2019) Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1267-1280.
Read now
Read now
Alicia Gayle, Scott Dickinson, Kevin Morris, Chris Poole, Alexander G Mathioudakis & Jørgen Vestbo. (2018) What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3485-3492.
Read now
Read now
Raquel Marçôa, Daniela Marta Rodrigues, Margarida Dias, Inês Ladeira, Ana Paula Vaz, Ricardo Lima & Miguel Guimarães. (2018) Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:1, pages 21-26.
Read now
Read now
Gaetano Caramori, Paolo Ruggeri, Paolo Casolari, Kian Fan Chung, Giuseppe Girbino & Ian M. Adcock. (2017) Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 11:12, pages 955-967.
Read now
Read now
Articles from other publishers (9)
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Yahong Chen, Wenhua Jian, Hongyan Shang & Chen Wang. (2022) Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study. Respiratory Research 23:1.
Crossref
Crossref
Smit Patel, Scott Dickinson, Kevin Morris, Helen F. Ashdown & James D. Chalmers. (2022) A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients. npj Primary Care Respiratory Medicine 32:1.
Crossref
Crossref
浩 杨. (2022) Research Progress on Discontinuation of ICS with Triple Inhaled Drugs for Chronic Obstructive Pulmonary Disease. Advances in Clinical Medicine 12:07, pages 6963-6974.
Crossref
Crossref
James D. Chalmers, Irena F. Laska, Frits M.E. Franssen, Wim Janssens, Ian Pavord, David Rigau, Melissa J. McDonnell, Nicolas Roche, Don D. Sin, Daiana Stolz, Samy Suissa, Jadwiga Wedzicha & Marc Miravitlles. (2020) Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline. European Respiratory Journal 55:6, pages 2000351.
Crossref
Crossref
S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, I. V. Leshchenko, S. I. Ovcharenko, E. I. Shmelev & M. Miravitls. (2019) Withdrawal of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Russian Pulmonology 29:3, pages 334-345.
Crossref
Crossref
Rafael Golpe, María Suárez-Valor, Iria Veiga-Teijeiro, Alejandro Veres-Racamonde & Luis A. Pérez-de-Llano. (2019) ¿Debe incluirse la función pulmonar en la estratificación de riesgo de la enfermedad pulmonar obstructiva crónica propuesta por GesEPOC?. Archivos de Bronconeumología 55:8, pages 436-437.
Crossref
Crossref
Rafael Golpe, María Suárez-Valor, Iria Veiga-Teijeiro, Alejandro Veres-Racamonde & Luis A. Pérez-de-Llano. (2019) Should Lung Function be Included in the Risk Stratification of Chronic Obstructive Pulmonary Disease Proposed by GesEPOC?. Archivos de Bronconeumología (English Edition) 55:8, pages 436-437.
Crossref
Crossref
Rosa Faner, Guillaume Noell, Joan Ramon Badia, Alejandra López-Giraldo, Per Bakke, Edwin K. Silverman, Ruth Tal-Singer & Alvar Agustí. (2018) Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort. Respiratory Medicine 141, pages 14-19.
Crossref
Crossref
Marc Miravitlles, Borja G. Cosío, Aurelio Arnedillo, Myriam Calle, Bernardino Alcázar-Navarrete, Cruz González, Cristóbal Esteban, Juan Antonio Trigueros, José Miguel Rodríguez González-Moro, José Antonio Quintano Jiménez & Adolfo Baloira. (2017) A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease. Respiratory Research 18:1.
Crossref
Crossref